Shanghai HeartCare (06609) Updates H Share Repurchase and Share Capital Structure

Bulletin Express

Oct 17

Shanghai HeartCare Medical Technology Corporation Limited (06609) announced details of a repurchase of its H shares on 17 October 2025. According to the filing, 19,500 H shares were bought back at prices ranging from HKD 54.10 to HKD 55.65, with a total consideration of HKD 1,071,950. After the transaction, the number of H shares in issue stands at 31,052,054, while treasury shares have increased to 513,750. The overall total of 31,565,804 H shares remains unchanged.

No changes were reported in the 7,268,604 unlisted shares, leaving the total number of shares at 38,834,408. The information also noted that a 30-day moratorium period is in effect until 16 November 2025 following the repurchase, in accordance with applicable listing rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1146634310"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146634310\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146634310?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146634310","market":"hk","top_or_hot":-1,"title":"Shanghai HeartCare (06609) Updates H Share Repurchase and Share Capital Structure","media":"Bulletin Express","content":"<p>Shanghai HeartCare Medical Technology Corporation Limited (06609) announced details of a repurchase of its H shares on 17 October 2025. According to the filing, 19,500 H shares were bought back at prices ranging from HKD 54.10 to HKD 55.65, with a total consideration of HKD 1,071,950. After the transaction, the number of H shares in issue stands at 31,052,054, while treasury shares have increased to 513,750. The overall total of 31,565,804 H shares remains unchanged.</p>\n<p>No changes were reported in the 7,268,604 unlisted shares, leaving the total number of shares at 38,834,408. The information also noted that a 30-day moratorium period is in effect until 16 November 2025 following the repurchase, in accordance with applicable listing rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai HeartCare (06609) Updates H Share Repurchase and Share Capital Structure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai HeartCare (06609) Updates H Share Repurchase and Share Capital Structure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-17 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai HeartCare Medical Technology Corporation Limited (06609) announced details of a repurchase of its H shares on 17 October 2025. According to the filing, 19,500 H shares were bought back at prices ranging from HKD 54.10 to HKD 55.65, with a total consideration of HKD 1,071,950. After the transaction, the number of H shares in issue stands at 31,052,054, while treasury shares have increased to 513,750. The overall total of 31,565,804 H shares remains unchanged.</p>\n<p>No changes were reported in the 7,268,604 unlisted shares, leaving the total number of shares at 38,834,408. The information also noted that a 30-day moratorium period is in effect until 16 November 2025 following the repurchase, in accordance with applicable listing rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06609","symbol_name":"心玮医疗-B","start_time":0,"source_url":"","article_id":"1146634310","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146634310","pubTimestamp":1760694169,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai HeartCare Medical Technology Corporation Limited (06609) announced details of a repurchase of its H shares on 17 October 2025. According to the filing, 19,500 H shares were bought back at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06609":"心玮医疗-B"},"translate_title":"上海心康(06609)更新H股回购及股本架构","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06609":1},"content_text":"Shanghai HeartCare Medical Technology Corporation Limited (06609) announced details of a repurchase of its H shares on 17 October 2025. According to the filing, 19,500 H shares were bought back at prices ranging from HKD 54.10 to HKD 55.65, with a total consideration of HKD 1,071,950. After the transaction, the number of H shares in issue stands at 31,052,054, while treasury shares have increased to 513,750. The overall total of 31,565,804 H shares remains unchanged.\nNo changes were reported in the 7,268,604 unlisted shares, leaving the total number of shares at 38,834,408. The information also noted that a 30-day moratorium period is in effect until 16 November 2025 following the repurchase, in accordance with applicable listing rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}